CD68 and Stroke: U-IGF1R+ hDSCs treatment showed significantly fewer CD68+ cells infiltration at the peri-infarct area at 3 days after stroke than that of F-IGF1R+ hDSCs and control rats (Fig. 6c and Fig. S6c).